$1.51 Billion is the total value of Hudson Executive Capital LP's 9 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 85.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DB | Buy | DEUTSCHE BANK A Gnamen akt | $877,973,000 | +9.6% | 67,389,676 | +0.5% | 58.30% | +17.2% |
| CTLP | New | CANTALOUPE INC | $142,270,000 | – | 11,995,765 | +100.0% | 9.45% | – |
| TVTY | TIVITY HEALTH INC | $126,165,000 | +17.9% | 4,795,310 | 0.0% | 8.38% | +26.1% | |
| VRAY | VIEWRAY INC | $97,513,000 | +51.7% | 14,774,684 | 0.0% | 6.48% | +62.3% | |
| EHTH | EHEALTH INC | $87,659,000 | -19.7% | 1,501,002 | 0.0% | 5.82% | -14.1% | |
| TALK | New | TALKSPACE INC | $84,347,000 | – | 10,150,000 | +100.0% | 5.60% | – |
| NTRA | Buy | NATERA INC | $66,856,000 | +24.9% | 588,886 | +11.7% | 4.44% | +33.6% |
| AKYA | New | AKOYA BIOSCIENCES INC | $20,693,000 | – | 1,069,984 | +100.0% | 1.37% | – |
| EGGFU | New | EG ACQUISITION CORPunit 99/99/9999 | $2,489,000 | – | 248,874 | +100.0% | 0.16% | – |
| USAT | Exit | USA TECHNOLOGIES INC | $0 | – | -11,995,765 | -100.0% | -8.73% | – |
| CATM | Exit | CARDTRONICS PLC | $0 | – | -8,644,880 | -100.0% | -20.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
| EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
| NATERA INC | 15 | Q4 2022 | 4.6% |
| CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
| VIEWRAY INC | 14 | Q2 2023 | 8.2% |
| ATRICURE INC | 13 | Q3 2019 | 20.9% |
| CIT GROUP INC | 11 | Q2 2018 | 26.4% |
| TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
| CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
| CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
| Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
| Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
| eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
| Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
| USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
| Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
| TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
| EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
| Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-02-21 |
| 4 | 2024-02-21 |
| SC 13D/A | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-07-21 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2023-02-07 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.